1. Home
  2. Browse Decisions
  3. IN RE OREXIGEN THERAPEUTICS, INC.
 

IN RE OREXIGEN THERAPEUTICS, INC.

Civ. No. 18-1873-CFC.

In re: OREXIGEN THERAPEUTICS, INC., et al., Chapter 11, Debtors. McKESSON CORPORATION INC. and McKESSON PATIENT RELATIONSHIP SOLUTIONS, Appellants, v. OREXIGEN THERAPEUTICS, INC., THE BAUPOST GROUP SECURITIES, L.L.C., ECOR1 CAPITAL FUND, L.P., ECOR1 CAPITAL FUND QUALIFIED, L.P., BIOTECHNOLOGY VALUE TRADING FUNDS OS, L.P., BIOTECHNOLOGY FUND L.P., BIOTECHNOLOGY VALUE FUND H, L.P., INVESTMENT 10, L.L.C., MSI BVF SPV LLC, and ROADRUNNER CO., Appellees.

United States District Court, D. Delaware.

January 15, 2019.

Editors Note
Applicable Law: 28 U.S.C. § 0158
Cause: 28 U.S.C. § 0158 Bankruptcy Appeal from Judgment / Order
Nature of Suit: 422 Bankruptcy Appeal (801)
Source: PACER

Attorney(s) appearing for the Case

McKesson Corporation & McKesson Patient Relationship Solutions, Appellants, represented by Jason Daniel Angelo , Reed Smith LLP.

Orexigen Therapeutics, Inc., Appellee, represented by Richard S. Cobb , Landis Rath & Cobb LLP & Kerri King Mumford , Landis Rath & Cobb LLP.

ORDER

BAP No. 18-58

Bk. No. 18-10518(KG)

At Wilmington this 15th day of January, 2019, having received a recommendation from Chief Magistrate Judge Mary Pat Thynge that this case be withdrawn from the mandatory referral for mediation and proceed through the...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases